{"id":"https://openalex.org/W2322856447","doi":"https://doi.org/10.1097/cmr.0000000000000074","title":"Four cases of rituximab-associated melanoma","display_name":"Four cases of rituximab-associated melanoma","publication_year":2014,"publication_date":"2014-04-17","ids":{"openalex":"https://openalex.org/W2322856447","doi":"https://doi.org/10.1097/cmr.0000000000000074","mag":"2322856447","pmid":"https://pubmed.ncbi.nlm.nih.gov/24743053"},"language":"en","primary_location":{"id":"doi:10.1097/cmr.0000000000000074","doi":"https://doi.org/10.1097/cmr.0000000000000074","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000074","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2322856447"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012423892","display_name":"C. Velter","orcid":"https://orcid.org/0000-0002-7270-3886","observed_orcids":["https://orcid.org/0000-0002-7270-3886"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Charles Velter","raw_affiliation_strings":["Departments of aDermatology bHemato-oncology cAnatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France","Dermatology","e-mail: [email\u00a0protected]","fax: +1 33 1 42 38 53 10","to Charles Velter, MD, Department of Dermatology, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10 Paris, France Tel: +1 33 1 42 38 53 11"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of aDermatology bHemato-oncology cAnatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France","institution_ids":["https://openalex.org/I4210144610"]},{"raw_affiliation_string":"Dermatology","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 33 1 42 38 53 10","institution_ids":[]},{"raw_affiliation_string":"to Charles Velter, MD, Department of Dermatology, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10 Paris, France Tel: +1 33 1 42 38 53 11","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109401670","display_name":"C\u00e9cile Pag\u00e8s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9cile Pag\u00e8s","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086508678","display_name":"Pierre Schneider","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Schneider","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062430267","display_name":"Am\u00e9lie Osio","orcid":"https://orcid.org/0000-0003-0861-0594","observed_orcids":["https://orcid.org/0000-0003-0861-0594"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Am\u00e9lie Osio","raw_affiliation_strings":["Anatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anatomo-pathology, Saint Louis Hospital, Paris Cedex 10, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103061699","display_name":"Pauline Brice","orcid":"https://orcid.org/0000-0002-9227-277X","observed_orcids":["https://orcid.org/0000-0002-9227-277X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Brice","raw_affiliation_strings":["Hemato-oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hemato-oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025478490","display_name":"C\u00e9l\u00e8ste Lebb\u00e9","orcid":"https://orcid.org/0000-0002-5854-7290","observed_orcids":["https://orcid.org/0000-0002-5854-7290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9leste Lebb\u00e9","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5012423892"],"corresponding_institution_ids":["https://openalex.org/I4210144610"],"apc_list":null,"apc_paid":null,"fwci":0.9638,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.74189227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"24","issue":"4","first_page":"401","last_page":"403"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03139999881386757,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7609999775886536},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8429999947547913},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-induced-malignancy","display_name":"drug-induced malignancy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5540000200271606},{"id":"https://openalex.org/keywords/metastatic-progression","display_name":"metastatic progression","score":0.6480000019073486},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.30799999833106995},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9421212673187256},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8165165185928345},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7526176571846008},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6929959058761597},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6754021644592285},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5270117521286011},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4814116954803467},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4123690724372864},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34140750765800476},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32932960987091064},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3249151110649109}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/cmr.0000000000000074","doi":"https://doi.org/10.1097/cmr.0000000000000074","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000074","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:24743053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24743053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W560463957","https://openalex.org/W2028672514","https://openalex.org/W2169778736"],"related_works":["https://openalex.org/W3212514839","https://openalex.org/W1984854090","https://openalex.org/W2336571720","https://openalex.org/W2066739515","https://openalex.org/W4235541869","https://openalex.org/W4242988159","https://openalex.org/W2791605161","https://openalex.org/W2152775747","https://openalex.org/W2148570361"],"abstract_inverted_index":{"Biological":[0],"agents":[1],"have":[2,13],"transformed":[3],"the":[4,17,44,47,61,81,103],"management":[5],"of":[6,20,30,46,105,113],"inflammatory":[7],"and":[8,23,42,74,111],"proliferative":[9],"disorders.":[10],"Safety":[11],"issues":[12],"been":[14],"raised,":[15],"particularly":[16],"increased":[18],"risk":[19],"opportunistic":[21],"infections":[22],"secondary":[24],"cancers.":[25],"We":[26],"report":[27],"four":[28],"cases":[29,115],"melanoma":[31,55,84],"worsening":[32],"or":[33,59],"occurring":[34],"after":[35,86],"rituximab":[36,70,91,106],"treatment":[37,89],"for":[38,92],"associated":[39,71],"B-cell":[40,66],"lymphoma,":[41],"discuss":[43],"accountability":[45],"molecule":[48],"in":[49,107],"this":[50,123],"process.":[51],"In":[52,80],"three":[53],"cases,":[54],"was":[56],"diagnosed":[57],"before":[58],"at":[60],"same":[62],"time":[63],"as":[64],"a":[65,93],"lymphoma":[67],"treated":[68],"with":[69,72,90],"chemotherapy":[73],"we":[75],"observed":[76],"rapid":[77],"metastatic":[78],"progression.":[79],"last":[82],"case,":[83],"appeared":[85],"5":[87],"years":[88],"follicular":[94],"lymphoma.":[95],"Although":[96],"it":[97],"is":[98],"premature":[99],"to":[100,118],"conclude":[101],"on":[102,122],"role":[104],"melanoma,":[108],"careful":[109],"follow-up":[110],"registration":[112],"such":[114],"are":[116],"important":[117],"gain":[119],"further":[120],"insight":[121],"topic.":[124]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
